Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-19

Clinical Trial Update: Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing indacaterol to tiotropium on inspiratory capacity in COPD patients, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indacaterol (Onbrez Breezhaler) (indacaterol)
  • Tiotropium (Spiriva) (tiotropium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-08-19